resveratrol has been researched along with entinostat in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Annunziato, L; Benarese, M; Branca, C; Cuomo, O; Lanzillotta, A; Pignataro, G; Pizzi, M; Sarnico, I; Spano, P | 1 |
Bellucci, A; Benarese, M; Mota, M; Parrella, E; Pizzi, M; Porrini, V; Rhein, S; Schwaninger, M | 1 |
1 review(s) available for resveratrol and entinostat
Article | Year |
---|---|
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction | 2022 |
3 other study(ies) available for resveratrol and entinostat
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
Topics: Acetylation; Animals; Benzamides; Brain; Brain Ischemia; Cell Hypoxia; Disease Models, Animal; Epigenesis, Genetic; Glucose; Histone Deacetylase Inhibitors; Histones; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; NF-kappa B; Pyridines; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factor RelA | 2013 |
Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia.
Topics: Animals; Antioxidants; Benzamides; Disease Models, Animal; Histone Deacetylase Inhibitors; Infarction, Middle Cerebral Artery; Inflammation; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Pyridines; Resveratrol | 2020 |